Cabaletta Bio (CABA)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from CABA's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Cabaletta Bio's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | -$46M | -$53M | -$68M | -$116M | -$168M |
| Free cash flow | -$35M | -$49M | -$54M | -$90M | -$132M |
| EPS (diluted) | -$1.80 | -$1.81 | -$1.65 | -$2.34 | -$2.10 |
| Operating margin | — | — | — | — | — |
Superinvestors who own CABA
From each investor's latest 13F filing (what a 13F shows).
Insider buying
Open-market purchases by Cabaletta Bio's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you. Every purchase since records began.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jan 21, 2026 | Mark Simon |
11,061 | $2.28 | $25,219 |
| Jan 21, 2026 | David J Chang |
8,800 | $2.26 | $19,888 |
| Jan 21, 2026 | Gwendolyn Binder |
11,312 | $2.19 | $24,773 |
| Jan 21, 2026 | Michael Gerard |
6,600 | $2.27 | $14,982 |
| Jan 21, 2026 | Shawn Tomasello |
22,725 | $2.21 | $50,222 |
| Jan 21, 2026 | Steve Gavel |
22,170 | $2.27 | $50,326 |
| Jan 21, 2026 | Steven Nichtberger |
45,000 | $2.24 | $100,800 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when CABA trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Cabaletta Bio insiders buying the stock?
7 open-market insider purchases of CABA in the last 12 months, from SEC Form 4 filings.
Companies like Cabaletta Bio
All Healthcare stocks · Biotechnology stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.